Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/6/2025 | $323.00 | Outperform → Mkt Perform | Bernstein |
| 6/26/2024 | $400.00 | Overweight | Piper Sandler |
| 5/30/2024 | $388.00 | Outperform | Robert W. Baird |
| 3/6/2024 | $393.00 | Overweight | Barclays |
| 2/5/2024 | $334.00 → $372.00 | Neutral → Overweight | Cantor Fitzgerald |
| 2/5/2024 | $327.00 → $354.00 | Sector Perform → Outperform | RBC Capital Mkts |
| 2/1/2024 | $355.00 → $370.00 | Hold → Buy | Deutsche Bank |
| 1/4/2024 | $330.00 → $372.00 | Mkt Perform → Outperform | Bernstein |
3 - Cigna Group (0001739940) (Issuer)
4 - Cigna Group (0001739940) (Issuer)
4 - Cigna Group (0001739940) (Issuer)
BLOOMFIELD, Conn., Sept. 10, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced that Brian Evanko, President and COO of The Cigna Group, and Ann Dennison, EVP and CFO of the Cigna Group will present at the Morgan Stanley 23rd Annual Global Healthcare Conference today, September 10, 2025, in New York, NY. The Cigna Group's presentation is expected to begin at approximately 8:30 a.m. ET. A live webcast of the presentation will be available at https://investors.thecignagroup.com/events-and-presentations/default.aspx in the Investor Relations section of
AM Best has assigned a Long-Term Issue Credit Rating (Long-Term IRs) of "bbb+" (Good) to The Cigna Group's (Cigna) (headquartered in Bloomfield, CT) (NYSE:CI) new senior unsecured notes. In addition, AM Best has assigned indicative Long-Term IRs on the recently filed shelf registration of Cigna. The outlook assigned to these Credit Ratings (ratings) is stable. (Please see below for a detailed list of the Long-Term IRs.) Concurrently, AM Best has withdrawn the ratings on the previous shelf registration that expired. All other ratings of Cigna remain unchanged. The proceeds from the debt issuances are expected to be used to repay $2 billion of loans outstanding under an existing term loan
Investment Further Enhances Evernorth's Participation in Growing Market for Specialty Medicine BLOOMFIELD, Conn., Sept. 2, 2025 /PRNewswire/ -- Evernorth Health Services ("Evernorth"), a subsidiary of The Cigna Group (NYSE:CI), today announced a $3.5 billion investment in Shields Health Solutions ("Shields" or the "Company"), a leading specialty pharmacy management company. Evernorth's investment coincides with Shields' establishment as a private standalone company upon its acquisition by Sycamore Partners ("Sycamore"), a leading private equity firm based in New York. This follows Sycamore's acquisition of Walgreens Boots Alliance ("WBA"), Shields' previous owner, which closed on August 28,
8-K - Cigna Group (0001739940) (Filer)
424B5 - Cigna Group (0001739940) (Filer)
424B5 - Cigna Group (0001739940) (Filer)
Bernstein downgraded The Cigna Group from Outperform to Mkt Perform and set a new price target of $323.00
Piper Sandler initiated coverage of The Cigna Group with a rating of Overweight and set a new price target of $400.00
Robert W. Baird initiated coverage of The Cigna Group with a rating of Outperform and set a new price target of $388.00
BLOOMFIELD, Conn., June 2, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced today that Michael J. Hennigan has been appointed to the organization's Board of Directors. His appointment is effective June 2. Mr. Hennigan is the Executive Chairman of Marathon Petroleum Corporation (MPC), an integrated downstream energy company, and MPLX, a diversified master limited partnership formed by MPC. He joined the company in 2017 and previously held the roles of Chief Executive Officer of MPC and Chairman, President and Chief Executive Officer of MPLX. Prior
As part of the company's initiative, thousands of employees logged 280,000 minutes of exercise over nine days Cigna leaders biked to Hartford, Conn.'s Dunkin' Park to host Boys & Girls Clubs members for a Yard Goats baseball game, with surprise appearances by UConn basketball coach and playersBLOOMFIELD, Conn., Sept. 9, 2024 /PRNewswire/ -- The Cigna Group (NYSE:CI) put out a challenge to its workforce this summer, inviting colleagues to join its first-ever Community Vitality Project, a nine-day challenge combining fun, fitness and fundraising. By logging more than 280,000 minutes of fitness activities and awarding their minutes spent moving, The Cigna Group employees helped determine how to
Brian Evanko to continue as Chief Financial Officer, will serve as new President and CEO of Cigna HealthcareAnn Dennison to join The Cigna Group as Deputy Chief Financial OfficerMike Triplett to retire by end of 2024 and Bryan Holgerson promoted to President of U.S. Commercial for Cigna HealthcareEric Palmer to assume expanded role leading enterprise strategy and corporate development, will continue as President and CEO of Evernorth Health ServicesBLOOMFIELD, Conn., Jan. 17, 2024 /PRNewswire/ -- The Cigna Group (NYSE:CI), a global health company, today announced leadership changes designed to continue accelerating growth across Evernorth Health Services and Cigna Healthcare.
SC 13G - Cigna Group (0001739940) (Subject)
SC 13G/A - Cigna Group (0001739940) (Subject)
SC 13G/A - Cigna Group (0001739940) (Subject)
AM Best has assigned a Long-Term Issue Credit Rating (Long-Term IRs) of "bbb+" (Good) to The Cigna Group's (Cigna) (headquartered in Bloomfield, CT) (NYSE:CI) new senior unsecured notes. In addition, AM Best has assigned indicative Long-Term IRs on the recently filed shelf registration of Cigna. The outlook assigned to these Credit Ratings (ratings) is stable. (Please see below for a detailed list of the Long-Term IRs.) Concurrently, AM Best has withdrawn the ratings on the previous shelf registration that expired. All other ratings of Cigna remain unchanged. The proceeds from the debt issuances are expected to be used to repay $2 billion of loans outstanding under an existing term loan
Total revenues for the second quarter 2025 increased 11% to $67.2 billionShareholders' net income for the second quarter 2025 was $1.5 billion, or $5.71 per shareAdjusted income from operations1 for the second quarter 2025 was $1.9 billion, or $7.20 per shareReaffirms 2025 outlook for adjusted income from operations1,2 of at least $29.60 per share2BLOOMFIELD, Conn., July 31, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today reported strong second quarter 2025 results, reflecting continued growth and solid performance across its diverse portfolio of businesses. "Listening, adapting, and innovating to meet the evolving needs of our patients, customers, and clients ena
BLOOMFIELD, Conn., July 22, 2025 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE: CI) today declared a cash dividend of $1.51 per share of its common stock, payable on September 18, 2025 to shareholders of record as of the close of business on September 4, 2025. About The Cigna Group The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and s